"Wessex cardiology offers the premium private cardiology device for patients in the south of England. Comprising twelve cardiologists and a full range of expertise for insured and self pay patients alike."

During the past decade, Wessex Cardiac Unit conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wessex Cardiac Unit" are "Coronary Artery Disease" (2 trials), "Coronary Disease" (2 trials) and "Coronary Restenosis" (2 trials). Many other conditions were trialed in "Wessex Cardiac Unit" in a lesser frequency.

Most popular intervention types in "Wessex Cardiac Unit" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "TAXUS® Liberté™" (1 trials), "XIENCE V® EECSS" (1 trials) and "XIENCE V® Everolimus Eluting Coronary Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wessex Cardiac Unit" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Wessex Cardiac Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Wessex Cardiac Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wessex Cardiac Unit, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".